Femasys Inc. (NASDAQ:FEMY) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Joshua N. Silverman Other companies: PharmaCyte Biotech, Inc. (Interim Chief Executive Officer, President, and Director · Since at least Aug 15, 2022); TAO Synergies Inc. (Executive Chairman · Since at least Jun 4, 2021); Petros Pharmaceuticals Inc (Vice-Chairman of the Board · Since at least Dec 1, 2020); Q/C Technologies, Inc. (Executive Chairman · Since at least Sep 6, 2018); Fabric.AI, Inc. (Chief Executive Officer, Director · Since at least Aug 15, 2016); Marker Therapeutics, Inc. (Director · Nov 28, 2016 – Oct 16, 2018 · Past); Neurotrope Inc (Director · Aug 4, 2016 – Dec 1, 2020 · Past); Protagenic Therapeutics, Inc. (Director · Feb 12, 2016 – Feb 21, 2020 · Past); MGT Capital Investments, Inc. (Director · Dec 31, 2015 – Dec 31, 2015 · Past); National Holdings Corporation (Director · Jul 28, 2014 – Sep 12, 2016 · Past) | Director · Since at least Nov 21, 2023 |
| Keith J Kendall Other companies: Aquestive Therapeutics, Inc. (CEO and President, Director · Jul 24, 2018 – Mar 10, 2022 · Past) | Director · Jun 14, 2023 – Jun 14, 2023 · Past |
| Kenneth D. Eichenbaum Other companies: InfuSystems Holdings, Inc. (Director · Since at least May 16, 2024) | Director · Since at least Mar 18, 2026 |
| Wendy Perrow Other companies: Bioanalytical Systems Inc (Director · Dec 10, 2015 – Sep 10, 2019 · Past) | Director · Jan 19, 2022 – Jun 21, 2023 · Past |
| Charles Larsen | Director · Since at least Jun 17, 2021 |
| Christine E Thomas | Chief Reg & Clinical Officer · Oct 10, 2023 – Jan 28, 2025 · Past |
| Daniel Scott Currie | Chief Operating Officer · Since at least Jul 3, 2023 |
| Dov Elefant | Chief Financial Officer · Since at least Jul 3, 2023 |
| Edward R Uzialko | Director · Since at least Jun 17, 2021 |
| Gary Thompson | Director · Jun 17, 2021 – Jun 17, 2021 · Past |
| Hoskin Violet Alexandria Kelley | VP, Clinical & Medical Affairs · Jun 17, 2021 – Jun 17, 2021 · Past |
| James H. Liu | Chief Medical Officer · Since at least Aug 21, 2025 |
| Jeffrey Mifek | Chief Clinical and Regulatory Affairs Officer · Since at least Jul 6, 2026 |
| Jeremy Sipos | Chief Technology Officer · Since at least Dec 16, 2025 |
| John Canning | Chief Operating Officer · Since at least Mar 30, 2026 |
| John Dyett | Director · Jun 17, 2021 – Jun 8, 2022 · Past |
| John Moorhead | Director · Since at least Oct 30, 2026 |
| John Q Adams Jr | Director · Jun 17, 2021 – Jun 8, 2022 · Past |
| Kathy Lee-Sepsick | Chief Executive Officer, Director · Since at least Jun 17, 2021 |
| Kathy Lee-Sepsick | President and Chief Executive Officer · Since at least Aug 11, 2026 |
| Kelley Stinson Nicholas | Chief Commercial Officer · Since at least Jun 23, 2025 |
| Richard D Spector | Chief Commercial Officer · Feb 12, 2024 – Feb 12, 2024 · Past |
| William Benson Witte | Director · Jun 17, 2021 – Dec 15, 2021 · Past |